However, coding IKZF1 mutations have been identified in familial B-ALL and ~0.9% of presumed sporadic pediatric B-ALL, most variants of which adversely affect IKZF1 function and response to treatment. This evidence concerns the gene IKZF1 and precursor B-cell acute lymphoblastic leukemia.